MRKMerck & Company
About Merck & Company
Merck (NYSE:MRK) operates in pharmaceuticals, providing innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Projects range from developing new therapies for unmet medical needs to manufacturing complex biomedical substances. Merck's primary objective is improving patient health and wellness through its research-intensive, innovation-driven strategy, aiming to maintain leadership in key segments, while ensuring ethical business practices and sustainability.
What is MRK known for?
Snapshot
Public US
Ownership
1891
Year founded
67571
Employees
New Jersey, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Products and/or services of Merck & Company
- Offering a revolutionary cancer immunotherapy, Pembrolizumab (Keytruda) is designed to inhibit the PD-1 pathway, unleashing the body's immune system to fight cancer cells.
- Gardasil, a vaccine developed to prevent the infection of certain types of Human Papillomavirus, aims to curb cervical and other cancer forms.
- Januvia, an oral medication designed to regulate blood sugar levels in adults with Type 2 diabetes, brings hope to those requiring diabetes management.
- Nuvaring, a flexible birth control vaginal ring that contains a combination of estrogen and progestin, aids in preventing unplanned pregnancies with proper use.
- Isentress, an FDA-approved medicine for treating HIV-1 infection, works by reducing the viral load and boosting immune system function.
- Zetia, a cholesterol-lowering drug primarily used in conjunction with a healthy diet, contributes to cardiovascular health, reducing the risk of heart disease and stroke.
Merck & Company executive team
- Mr. Robert M. Davis J.D.Chairman, President & CEO
- Ms. Caroline A. LitchfieldExecutive VP & CFO
- Ms. Betty D. LarsonExecutive VP & Chief Human Resources Officer
- Mr. Richard R. DeLuca Jr.Executive VP & President of Merck Animal Health
- Dr. Dean Y. Li M.D., Ph.D.Executive VP & President of Merck Research Laboratories
- Mr. Dalton E. Smart IIISenior VP of Finance, Principal Accounting Officer & Global Controller
- Mr. David Michael WilliamsExecutive VP and Chief Information & Digital Officer
- Mr. Peter DannenbaumVice President of Investor Relations
- Ms. Jennifer L. Zachary J.D.Executive VP & General Counsel
- Mr. Sanat ChattopadhyayExecutive VP & President of Merck Manufacturing Division